Biotech Innovator Divine Skin Partners with Giant Ranbaxy to Sell Hair-Growth Treatments

MIAMI BEACH, Fla., July 18, 2011 /PRNewswire/ -- Biotech pioneer Divine Skin Inc. (DSKX) announced a partnership with India's largest pharmaceutical company, Ranbaxy Laboratories, to sell the DS Laboratories line of topical hair-growth treatments through its massive distribution pipeline.

With its strong presence in the top pharmaceutical markets, Ranbaxy offers Divine Skin an expanded global distribution network. With its innovative line of hair-growth products, Divine Skin offers Ranbaxy several topical formulations proven to work both at the vertex of the scalp and at the hairline, unlike other brands.

"This agreement is a game changer for Divine Skin investors," declared CEO Daniel Khesin. "Ranbaxy is certainly has the resources to develop its own hair-growth brand, yet it has chosen to partner with Divine Skin. It's a powerful endorsement of our cutting-edge technologies. Now our challenge is to accelerate production to keep up with sales."

The DS Laboratories brand expands the treatment options available for men and women suffering hair loss and thinning. Products include the Spectral line of leave-in treatments and the Revita line of shampoo, conditioner, and eyelash treatment.

The comprehensive formulas blend various combinations of minoxidil, finasteride, Aminexil, peptides, procyanidin, stem cells, spin traps, dihydrotestosterone inhibitors, and other powerful ingredients. A proprietary Nanosome delivery system encapsulates active compounds for deeper penetration, longer persistence, and greater efficacy.

About Ranbaxy

Ranbaxy Laboratories is a top-20 pharmaceutical company manufacturing a wide range of high-quality generic medications. Headquartered near New Delhi, the company has global revenue of $1.9 billion, customers in 125 countries, presence in 46 countries, and manufacturing facilities in seven countries.

Already a manufacturing and distribution powerhouse, the company focuses on research and development of innovative drugs for its future growth (www.Ranbaxy.com).

About Divine Skin

Divine Skin Inc. leads in the development of biotechnology for topical, nutritional, and pharmaceutical therapies. It markets worldwide through online and specialty retailers, cosmetics wholesalers, salons, and medical offices.

DS Laboratories, its flagship brand, offers high-performance topical solutions to restore growth and radiance to hair, suppress dandruff and unwanted hair, control acne, improve hygiene, and reduce cellulite and wrinkles. Bioavailability is enhanced through encapsulation (www.dslaboratories.com).

The Sigma Skin brand sells through upscale retailers like Neiman Marcus in the United States and Harvey Nichols in the United Kingdom. The topical products address hair loss and other signs of aging (www.sigmaskin.com).

Polaris Research Laboratories makes high-potency minoxidil-based hair-growth formulas (www.polarisresearchlabs.com).

The Pure Guild offers purity with performance: Botanical compounds proven effective in clinical trials are extracted without industrial solvents or damaging heat and are sold through premium retailers (www.thepureguild.com).

NutraOrigin blends nutritional supplements that address the health concerns expressed by consumers, including fatigue, headache, obesity, mobility, menopause, erectile dysfunction, and others. In clinical trials for the US government, its Omega line proved to enhance mental function (www.nutraorigin.com).

SOURCE Divine Skin Inc.